Mohammad-Reza Delnavazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad-Reza Delnavazi has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Mahnaz Khanavi
Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Mohammad Ali Faramarzi
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications Somayeh Mojtabavi
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3 shared publicationsAbbas Hadjiakhoondi
Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsAli Dehnoee
Kharazmi University
2 shared publications- Farid Dabaghian
Department of Pharmacognosy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 19 August 2026
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 34  (2) , 60
Immunomodulatory effects of glycyrrhizin and glucomannan on cytokine gene expression in human PBMCs: implications for vaccine adjuvant development
- 19 August 2026
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 34  (2) , 60
Immunomodulatory effects of glycyrrhizin and glucomannan on cytokine gene expression in human PBMCs: implications for vaccine adjuvant development
- Open Access
- 9 August 2026
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 21  (3) , e171846
Boswellia sacra Flueck. Oleo-gum-resin Nanophytosome: Development, Standardization, and Cholinesterase Inhibitory Potential
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cholinergic dysfunction. The limited efficacy of current acetylcholinesterase inhibitors underscores the need for novel therapeutic approaches. Objectives: This study evaluated the acetylcholinesterase inhibitory activity of Boswellia sacra extracts and their phytosomal formulations. Methods: The methanolic extract of B. sacra was fractionated using potassium hydroxide (KOH) and ethyl acetate to obtain a boswellic acid-enriched fraction, which was further purified by silica gel chromatography to yield two derivatives identified by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy. A phytosomal formulation was prepared using soy lecithin and cholesterol via high-shear homogenization followed by ultrasonication. The optimized nanophytosome was characterized by dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and scanning electron microscopy (SEM). Entrapment efficiency, stability, the in vivo release profile, cholinesterase inhibitory activity was assessed using Ellman’s method. Results: Phytochemical analysis yielded 3-acetyl-11-keto-boswellic acid (1) and 11-keto-boswellic acid (2), and compound 1 was used for standardization. The optimized phytosome exhibited a mean particle size of 112 ± 12.28 nm, a polydispersity index (PDI) of 0.23 ± 0.1, a zeta potential of -53 ± 5.87 mV, and an entrapment efficiency of 75.3 ± 1.47%. FTIR and DSC confirmed molecular interactions between lecithin and the extract, whereas TEM and SEM revealed spherical morphology. The optimized phytosomal formulation demonstrated a gradual release profile, reaching 92% after 12 hours, and increased acetylcholinesterase inhibition to 61.0 ± 10.7% (half-maximal inhibitory concentration [IC50], 177.9 ± 26.8 µg/mL) compared with the non-formulated extract. It also showed moderate butyrylcholinesterase inhibition (42 - 48%) and selectivity for acetylcholinesterase inhibition. Conclusions: The optimized phytosomal formulation enhanced in vitro acetylcholinesterase inhibitory activity compared with the non-formulated extract, indicating the potential of this delivery system to improve the biological activity of Boswellia constituents in cell-free enzyme assays. However, these findings are preliminary and limited to in vitro experiments. Further studies are required to assess blood–brain barrier permeability, neuronal uptake, pharmacokinetics, and in vivo therapeutic efficacy.
- 9 August 2026
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 21  (3) , e171846
Open AccessBoswellia sacra Flueck. Oleo-gum-resin Nanophytosome: Development, Standardization, and Cholinesterase Inhibitory Potential
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cholinergic dysfunction. The limited efficacy of current acetylcholinesterase inhibitors underscores the need for novel therapeutic approaches. Objectives: This study evaluated the acetylcholinesterase inhibitory activity of Boswellia sacra extracts and their phytosomal formulations. Methods: The methanolic extract of B. sacra was fractionated using potassium hydroxide (KOH) and ethyl acetate to obtain a boswellic acid-enriched fraction, which was further purified by silica gel chromatography to yield two derivatives identified by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy. A phytosomal formulation was prepared using soy lecithin and cholesterol via high-shear homogenization followed by ultrasonication. The optimized nanophytosome was characterized by dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and scanning electron microscopy (SEM). Entrapment efficiency, stability, the in vivo release profile, cholinesterase inhibitory activity was assessed using Ellman’s method. Results: Phytochemical analysis yielded 3-acetyl-11-keto-boswellic acid (1) and 11-keto-boswellic acid (2), and compound 1 was used for standardization. The optimized phytosome exhibited a mean particle size of 112 ± 12.28 nm, a polydispersity index (PDI) of 0.23 ± 0.1, a zeta potential of -53 ± 5.87 mV, and an entrapment efficiency of 75.3 ± 1.47%. FTIR and DSC confirmed molecular interactions between lecithin and the extract, whereas TEM and SEM revealed spherical morphology. The optimized phytosomal formulation demonstrated a gradual release profile, reaching 92% after 12 hours, and increased acetylcholinesterase inhibition to 61.0 ± 10.7% (half-maximal inhibitory concentration [IC50], 177.9 ± 26.8 µg/mL) compared with the non-formulated extract. It also showed moderate butyrylcholinesterase inhibition (42 - 48%) and selectivity for acetylcholinesterase inhibition. Conclusions: The optimized phytosomal formulation enhanced in vitro acetylcholinesterase inhibitory activity compared with the non-formulated extract, indicating the potential of this delivery system to improve the biological activity of Boswellia constituents in cell-free enzyme assays. However, these findings are preliminary and limited to in vitro experiments. Further studies are required to assess blood–brain barrier permeability, neuronal uptake, pharmacokinetics, and in vivo therapeutic efficacy.
- Open Access
- 28 August 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20  (8)
Dose-Specific Modulation of Signaling Pathways by Extract of Onosma microcarpum During Distinct Phases of Wound Healing in a Rat Model
Background: Wound healing progresses through phases of homeostasis, inflammation, proliferation, and remodeling, regulated by signaling pathways. The root extract of Onosma microcarpum (OM), traditionally used in Western Iran for wound care, contains bioactive compounds like alkannin, shikonin, and polyphenols, potentially enhancing healing. This study evaluates OM's effects on wound healing through the signaling pathways in each phase. Methods: Dried OM root was formulated into ointments, and male Wistar rats with excisional wounds were treated with OM (0.2% or 1%) or vehicle. Wound closure rate, histological and gene expression analyses were conducted on days 3, 8, and 14, measuring inflammation, granulation, angiogenesis, and collagen formation. The mRNA expression of cytokines (Interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α)), growth factors (Transforming Growth Factor-β1 (TGF-β1), platelet-derived growth factor (PDGF)), and cell regulators (extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinases (JNK), p38 mitogen-activated protein kinase (p38 MAPK)) were analyzed. Results: OM at 0.2%, significantly modulated key pathways in wound healing. By day 3, OM reduced TNF-α ( P = 0.003) and IL-1β ( P = 0.008), decreasing inflammation and JNK activity ( P = 0.009). On day 8, OM further reduced IL-6 ( P = 0.002) and p38 MAPK ( P = 0.005) while increasing TGF-β1 ( P = 0.008) and PDGF ( P = 0.001), promoting proliferation. By day 14, increased ERK ( P = 0.008) and p38 MAPK ( P = 0.002) activity facilitated tissue repair. Wounds treated with 0.2% OM showed better outcomes than 1%, with more organized collagen (mean score 3.0 vs 2.3, P = 0.021), improved angiogenesis (3.4 vs 2.5, P = 0.038), and higher wound closure (87% vs 69%, P = 0.023). Conclusion: OM enhances wound healing by targeting each phase: reducing early inflammation, promoting mid-phase fibroblast proliferation, and supporting collagen organization in remodeling. These targeted effects suggest OM's therapeutic potential for wound repair.
- 28 August 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20  (8)
Open AccessDose-Specific Modulation of Signaling Pathways by Extract of Onosma microcarpum During Distinct Phases of Wound Healing in a Rat Model
Background: Wound healing progresses through phases of homeostasis, inflammation, proliferation, and remodeling, regulated by signaling pathways. The root extract of Onosma microcarpum (OM), traditionally used in Western Iran for wound care, contains bioactive compounds like alkannin, shikonin, and polyphenols, potentially enhancing healing. This study evaluates OM's effects on wound healing through the signaling pathways in each phase. Methods: Dried OM root was formulated into ointments, and male Wistar rats with excisional wounds were treated with OM (0.2% or 1%) or vehicle. Wound closure rate, histological and gene expression analyses were conducted on days 3, 8, and 14, measuring inflammation, granulation, angiogenesis, and collagen formation. The mRNA expression of cytokines (Interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α)), growth factors (Transforming Growth Factor-β1 (TGF-β1), platelet-derived growth factor (PDGF)), and cell regulators (extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinases (JNK), p38 mitogen-activated protein kinase (p38 MAPK)) were analyzed. Results: OM at 0.2%, significantly modulated key pathways in wound healing. By day 3, OM reduced TNF-α ( P = 0.003) and IL-1β ( P = 0.008), decreasing inflammation and JNK activity ( P = 0.009). On day 8, OM further reduced IL-6 ( P = 0.002) and p38 MAPK ( P = 0.005) while increasing TGF-β1 ( P = 0.008) and PDGF ( P = 0.001), promoting proliferation. By day 14, increased ERK ( P = 0.008) and p38 MAPK ( P = 0.002) activity facilitated tissue repair. Wounds treated with 0.2% OM showed better outcomes than 1%, with more organized collagen (mean score 3.0 vs 2.3, P = 0.021), improved angiogenesis (3.4 vs 2.5, P = 0.038), and higher wound closure (87% vs 69%, P = 0.023). Conclusion: OM enhances wound healing by targeting each phase: reducing early inflammation, promoting mid-phase fibroblast proliferation, and supporting collagen organization in remodeling. These targeted effects suggest OM's therapeutic potential for wound repair.
- 8 November 2024
- Published by Universitatea Dunarea de Jos din Galati in The Annals of the University Dunarea de Jos of Galati. Fascicle VI - Food Technology
- Vol. 48  (2) , 174-191
Exploring the nutritional benefits of acorns: phytochemical profiles and biological activity
Acorn, the fruit of Quercus species, is an edible nut with a long history in human diet and food resources. The study aimed to investigate the nutritional profiles of kernels and pericarps of acorns from Q. castaneifolia (Qc) and Q. brantii (Qb). Analysis of the Qc kernel revealed a high starch content (18.7±1.5%) and a lipid fraction rich in oleic acid (42.0%) and linoleic acid (34.1%). The Qb acorns exhibited a high quantity of total phenols (386.7 mg g−1 as gallic acid equivalent) and protein (1.30±0.19 mg g–1). Phytochemical analysis of the pericarp from Qc revealed a great flavonoid content (146.4 mg g−1 as catechin equivalent), contributing to its excellent antioxidant activity, as demonstrated by ABTS assays. The essential oil of the kernels from both acorn species contained α-pinene, heptanal, β-myrcene, limonene, methyl hexadecanoate, 2,5-Bis(1,1-dimethylethyl) phenol, 2,6-dimethyl naphthalene, and n-nonanal. The extract of Qc acorns exhibited inhibitory effects on the growth of S. aureus, S. epidermidis, P. aeruginosa, and E. coli as common pathogenic bacteria. With its rich compositional profiles and potent antioxidant and antimicrobial properties, acorn shows great promise in nutraceutical and nutritional benefits.
- 8 November 2024
- Published by Universitatea Dunarea de Jos din Galati in The Annals of the University Dunarea de Jos of Galati. Fascicle VI - Food Technology
- Vol. 48  (2) , 174-191
Exploring the nutritional benefits of acorns: phytochemical profiles and biological activity
Acorn, the fruit of Quercus species, is an edible nut with a long history in human diet and food resources. The study aimed to investigate the nutritional profiles of kernels and pericarps of acorns from Q. castaneifolia (Qc) and Q. brantii (Qb). Analysis of the Qc kernel revealed a high starch content (18.7±1.5%) and a lipid fraction rich in oleic acid (42.0%) and linoleic acid (34.1%). The Qb acorns exhibited a high quantity of total phenols (386.7 mg g−1 as gallic acid equivalent) and protein (1.30±0.19 mg g–1). Phytochemical analysis of the pericarp from Qc revealed a great flavonoid content (146.4 mg g−1 as catechin equivalent), contributing to its excellent antioxidant activity, as demonstrated by ABTS assays. The essential oil of the kernels from both acorn species contained α-pinene, heptanal, β-myrcene, limonene, methyl hexadecanoate, 2,5-Bis(1,1-dimethylethyl) phenol, 2,6-dimethyl naphthalene, and n-nonanal. The extract of Qc acorns exhibited inhibitory effects on the growth of S. aureus, S. epidermidis, P. aeruginosa, and E. coli as common pathogenic bacteria. With its rich compositional profiles and potent antioxidant and antimicrobial properties, acorn shows great promise in nutraceutical and nutritional benefits.
- Open Access
- 14 September 2024
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 19  (4)
Cytotoxic Activity and Phytochemical Analysis of Artemisia biennis Essential Oils at Different Growth Stages
Background: The Artemisia genus is well-known for its medicinal properties, particularly in Iranian traditional medicine. Artemisia biennis, a species within this genus, is widely distributed across Iranian rangelands. Objectives: This study aimed to evaluate the cytotoxic activity and chemical composition of essential oils (EO) isolated from the aerial parts of A. biennis in Iran at different growth stages. Methods: The aerial parts of A. biennis from northeast Iran were collected during June (early vegetative stage), July (pre-flowering stage), August (full-flowering stage), and October (late vegetative stage). The essential oils (EOs) of the A. biennis species were extracted by hydro-distillation using a Clevenger-type apparatus and analyzed using gas chromatography–mass spectrometry (GC/MS). The cytotoxic activity of the EOs against normal fibroblasts, MCF-7, and HT-29 cell lines was evaluated using the MTT assay. Results: Data from GC/MS analysis revealed that (Z)-nerolidol (22.62 - 54.4%), (E)-β-farnesene (6.89-16.38%), and (Z)-tonghaosu (12.33 - 18.61%) were the most abundant chemical constituents. The essential oil (EO) of A. biennis was characterized by a high content of oxygenated sesquiterpenes, with (Z)-nerolidol being the main constituent identified. Based on the MTT assay, the EO of the plant species collected in June exhibited the most potent cytotoxicity against MCF-7 (IC50 = 2.84 ± 0.15 µg/mL) and HT-29 cell lines (IC50 = 2.41 ± 0.2 µg/mL). Conclusions: The growth stage of A. biennis affects EO yields, the composition of extracted secondary metabolites, and cytotoxic activity. A. biennis EOs can be considered potential sources of cytotoxic phytochemicals.
- 14 September 2024
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 19  (4)
Open AccessCytotoxic Activity and Phytochemical Analysis of Artemisia biennis Essential Oils at Different Growth Stages
Background: The Artemisia genus is well-known for its medicinal properties, particularly in Iranian traditional medicine. Artemisia biennis, a species within this genus, is widely distributed across Iranian rangelands. Objectives: This study aimed to evaluate the cytotoxic activity and chemical composition of essential oils (EO) isolated from the aerial parts of A. biennis in Iran at different growth stages. Methods: The aerial parts of A. biennis from northeast Iran were collected during June (early vegetative stage), July (pre-flowering stage), August (full-flowering stage), and October (late vegetative stage). The essential oils (EOs) of the A. biennis species were extracted by hydro-distillation using a Clevenger-type apparatus and analyzed using gas chromatography–mass spectrometry (GC/MS). The cytotoxic activity of the EOs against normal fibroblasts, MCF-7, and HT-29 cell lines was evaluated using the MTT assay. Results: Data from GC/MS analysis revealed that (Z)-nerolidol (22.62 - 54.4%), (E)-β-farnesene (6.89-16.38%), and (Z)-tonghaosu (12.33 - 18.61%) were the most abundant chemical constituents. The essential oil (EO) of A. biennis was characterized by a high content of oxygenated sesquiterpenes, with (Z)-nerolidol being the main constituent identified. Based on the MTT assay, the EO of the plant species collected in June exhibited the most potent cytotoxicity against MCF-7 (IC50 = 2.84 ± 0.15 µg/mL) and HT-29 cell lines (IC50 = 2.41 ± 0.2 µg/mL). Conclusions: The growth stage of A. biennis affects EO yields, the composition of extracted secondary metabolites, and cytotoxic activity. A. biennis EOs can be considered potential sources of cytotoxic phytochemicals.
- 19 August 2024
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 32  (2) , 825-899
A review of the ethnomedicinal, phytochemical, and pharmacological properties of the Ferulago genus based on Structure–Activity Relationship (SAR) of coumarins
Background The Ferluago W.D.J. Koch genus includes 48 accepted perennial herbs that are distributed in the Mediterranean region, Southeast Europe, Central and Middle East of Asia. These plants are widely used in folk and conventional medicine due to their biological benefits such as anti-microbial, anti-inflammatory, anti-cancer, and immunomodulatory properties. Conducting a comprehensive review based on the structure activity relationships (SARs) of the coumarins, which has not been previously documented, can lead to a better insight into the genus Ferulago and its beneficial therapeutic activities. Methods This review covers literature from 1969 to 2023, were collected from various scientific electronic databases to review phytochemical, pharmacological, and ethnopharmacological data of Ferulago species, as well as latest information on the SAR of reported coumarins from this genus. Results Phytochemical studies showed that the biological actions of this genus are mediated by the reported specialized metabolites, such as coumarins and flavonoids. Simple coumarins, prenylated coumarins, furanocoumarins, and pyranocoumarins are the largest subclasses of coumarins found in diverse Ferulago species, which have discussed the biological effects of them with a focus on the Structure–Activity Relationship (SAR). For example, prenylated coumarins have shown potential leishmanicidal and anti-neuropsychiatric effects when substituted with a prenyl group at the 7-hydroxy, as well as the C6 and C8 positions in their scaffold. Similarly, furanocoumarins exhibit varied biological activities such as anti-inflammatory, anti-proliferative, and anti-convulsant effects. Modifying substitutions at the C5 and C6 positions in furanocoumarins can enhance these activities. Conclusion This study conducted a comprehensive review of all available information on the phytochemical and pharmacological characteristics of Ferulago species. Given the high occurrence of coumarins in this genus, which exhibit potential anti-Alzheimer and anti-microbial properties, it presents promising new therapeutic avenues for addressing these common issues. Further investigation is needed to understand the molecular-level mechanisms of action and to explore their clinical applications. Graphical Abstract
- 19 August 2024
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 32  (2) , 825-899
A review of the ethnomedicinal, phytochemical, and pharmacological properties of the Ferulago genus based on Structure–Activity Relationship (SAR) of coumarins
Background The Ferluago W.D.J. Koch genus includes 48 accepted perennial herbs that are distributed in the Mediterranean region, Southeast Europe, Central and Middle East of Asia. These plants are widely used in folk and conventional medicine due to their biological benefits such as anti-microbial, anti-inflammatory, anti-cancer, and immunomodulatory properties. Conducting a comprehensive review based on the structure activity relationships (SARs) of the coumarins, which has not been previously documented, can lead to a better insight into the genus Ferulago and its beneficial therapeutic activities. Methods This review covers literature from 1969 to 2023, were collected from various scientific electronic databases to review phytochemical, pharmacological, and ethnopharmacological data of Ferulago species, as well as latest information on the SAR of reported coumarins from this genus. Results Phytochemical studies showed that the biological actions of this genus are mediated by the reported specialized metabolites, such as coumarins and flavonoids. Simple coumarins, prenylated coumarins, furanocoumarins, and pyranocoumarins are the largest subclasses of coumarins found in diverse Ferulago species, which have discussed the biological effects of them with a focus on the Structure–Activity Relationship (SAR). For example, prenylated coumarins have shown potential leishmanicidal and anti-neuropsychiatric effects when substituted with a prenyl group at the 7-hydroxy, as well as the C6 and C8 positions in their scaffold. Similarly, furanocoumarins exhibit varied biological activities such as anti-inflammatory, anti-proliferative, and anti-convulsant effects. Modifying substitutions at the C5 and C6 positions in furanocoumarins can enhance these activities. Conclusion This study conducted a comprehensive review of all available information on the phytochemical and pharmacological characteristics of Ferulago species. Given the high occurrence of coumarins in this genus, which exhibit potential anti-Alzheimer and anti-microbial properties, it presents promising new therapeutic avenues for addressing these common issues. Further investigation is needed to understand the molecular-level mechanisms of action and to explore their clinical applications. Graphical Abstract
- 30 June 2024
- Published by Springer Nature
- p. 193-210
Gene-Based Management of Alzheimer’s Disease: Role of Coumarins of Ferulago Genus
- 30 June 2024
- Published by Springer Nature
- p. 193-210
Gene-Based Management of Alzheimer’s Disease: Role of Coumarins of Ferulago Genus
- 20 June 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 150, 107580
α-Glucosidase inhibition assay of galbanic acid and it amide derivatives: New excellent semi-synthetic α-glucosidase inhibitors
- 20 June 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 150, 107580
α-Glucosidase inhibition assay of galbanic acid and it amide derivatives: New excellent semi-synthetic α-glucosidase inhibitors
- Open Access
- 29 June 2023
- Published by Springer Nature in Research Square
Anticancer potential of furanocoumarins and flavonoids of Heracleum persicum fruit
Heracleum persicum Desf. ex Fischer (Umbelliferae) is a herbaceous perennial plant distributed in Iran and Turkey. The aromatic fruits of this plant are commonly used as food additive, carminative, antiseptic and tonic. The present study was designed to isolate non-volatile constituents of H. persicum fruits and evaluate their anti-tumor potentials against different cancer cells. Phytochemical analysis using chromatography on silica gel and Sephadex LH-20 columns resulted in the isolation of phellopterin (1), angelicin (2), pimpinellin (3), bergapten (4), isopimpinellin (5) and xanthotoxin (6) from dichloromethane fraction along with apterin (7), isorhamnetin 3-O-glucoside (8), isorhamnetin 3-O-rutinoside (narcissin) (9), and quercetin 3-O-rutinoside (rutin) from n-butanol fraction of H. persicum fruits extract. 1H-NMR and 13C-NMR spectral analyses were applied to characterize the chemical structures. In MTT assay all of the tested compounds demonstrated preferential cytotoxic activity against cancer cells (IC50; 40–370 µg/mL) in comparison with HUVEC normal cells (IC50; > 1000 µg/mL). Among the compounds phellopterin (1) showed the highest anti-tumor activity toward U-266, SK-MM-1 and RPMI-8226 multiple myeloma cells with IC50 values of 44.3 ± 1.4, 69.1 ± 1.2 and 85.7 ± 1.8 µg/mL, respectively.
- 29 June 2023
- Published by Springer Nature in Research Square
Open AccessAnticancer potential of furanocoumarins and flavonoids of Heracleum persicum fruit
Heracleum persicum Desf. ex Fischer (Umbelliferae) is a herbaceous perennial plant distributed in Iran and Turkey. The aromatic fruits of this plant are commonly used as food additive, carminative, antiseptic and tonic. The present study was designed to isolate non-volatile constituents of H. persicum fruits and evaluate their anti-tumor potentials against different cancer cells. Phytochemical analysis using chromatography on silica gel and Sephadex LH-20 columns resulted in the isolation of phellopterin (1), angelicin (2), pimpinellin (3), bergapten (4), isopimpinellin (5) and xanthotoxin (6) from dichloromethane fraction along with apterin (7), isorhamnetin 3-O-glucoside (8), isorhamnetin 3-O-rutinoside (narcissin) (9), and quercetin 3-O-rutinoside (rutin) from n-butanol fraction of H. persicum fruits extract. 1H-NMR and 13C-NMR spectral analyses were applied to characterize the chemical structures. In MTT assay all of the tested compounds demonstrated preferential cytotoxic activity against cancer cells (IC50; 40–370 µg/mL) in comparison with HUVEC normal cells (IC50; > 1000 µg/mL). Among the compounds phellopterin (1) showed the highest anti-tumor activity toward U-266, SK-MM-1 and RPMI-8226 multiple myeloma cells with IC50 values of 44.3 ± 1.4, 69.1 ± 1.2 and 85.7 ± 1.8 µg/mL, respectively.
- 28 April 2023
- Published by Elsevier in Fitoterapia
- Vol. 168, 105517
New antiprotozoal sesquiterpene derivatives from Dorema glabrum Fisch & C.A.Mey
- 28 April 2023
- Published by Elsevier in Fitoterapia
- Vol. 168, 105517
New antiprotozoal sesquiterpene derivatives from Dorema glabrum Fisch & C.A.Mey